Keyphrases
Hazard Ratio
100%
Acute Myeloid Leukemia
100%
Confidence Interval
100%
Unrelated Donor
100%
Myelodysplastic Syndrome
100%
Haploidentical Donor
100%
Hematopoietic Cell Transplantation
83%
Haploidentical
66%
Graft-versus-host Disease (GvHD)
50%
Post-transplantation Cyclophosphamide (PTCy)
50%
Donor Age
33%
Unrelated Hematopoietic Stem Cell Transplantation
33%
Leukemia Patients
16%
Overall Survival
16%
Haploidentical Hematopoietic Stem Cell Transplantation
16%
Multivariate Analysis
16%
Low Dose Rate
16%
Relapse Rate
16%
Non-relapse Mortality
16%
Retrospective Analysis
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Cell Donors
16%
Reduced-intensity Conditioning
16%
Myeloablative Conditioning
16%
Graft-versus-host Disease Prophylaxis
16%
Donor Groups
16%
Donor Selection
16%
Influence of Age
16%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Hematopoietic Cell
100%
Cell Transplantation
100%
Myelodysplastic Syndrome
100%
Hazard Ratio
75%
Cyclophosphamide
37%
Transplantation
37%
Acute Graft Versus Host Disease
25%
Overall Survival
12%
Multivariate Analysis
12%
Recurrence Risk
12%
Non-Relapse Mortality
12%
Myeloablative Conditioning
12%
Reduced Intensity Conditioning
12%
Graft Versus Host Reaction
12%
Chronic Graft Versus Host Disease
12%
Prophylaxis
12%
Donor Selection
12%
Immunology and Microbiology
Hematopoietic Cell
100%
Myeloid
100%
Cell Transplantation
100%
Cyclophosphamide
37%
Conditioning
25%
Acute Graft Versus Host Disease
25%
Overall Survival
12%
Graft-Versus-Host Disease
12%
Chronic Graft Versus Host Disease
12%
Donor Selection
12%